Privia HealthPRVA
PRVA
About: Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Employees: 1,102
0
Funds holding %
of 7,139 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
198% more call options, than puts
Call options by funds: $7.97M | Put options by funds: $2.68M
100% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 2 (+1) [Q4]
53% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 64
8% more capital invested
Capital invested by funds: $2.18B [Q3] → $2.35B (+$165M) [Q4]
0.22% less ownership
Funds ownership: 100.23% [Q3] → 100.01% (-0.22%) [Q4]
3% less funds holding
Funds holding: 232 [Q3] → 225 (-7) [Q4]
13% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 30
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$25
2%
upside
Avg. target
$26
5%
upside
High target
$28
14%
upside
6 analyst ratings
6 positive
100%
0 neutral
0%
0 negative
0%
JMP Securities Constantine Davides 40% 1-year accuracy 12 / 30 met price target | 6%upside $26 | Market Outperform Maintained | 14 Feb 2025 |
Needham Ryan MacDonald 56% 1-year accuracy 38 / 68 met price target | 2%upside $25 | Buy Reiterated | 15 Jan 2025 |
Needham Matthew Sheerin 72% 1-year accuracy 21 / 29 met price target | 2%upside $25 | Buy Initiated | 10 Jan 2025 |
Stephens & Co. Jeff Garro 50% 1-year accuracy 3 / 6 met price target | 6%upside $26 | Overweight Reiterated | 7 Jan 2025 |
Macquarie Tao Qiu 29% 1-year accuracy 5 / 17 met price target | 2%upside $25 | Outperform Initiated | 16 Dec 2024 |
Financial journalist opinion
Neutral
GlobeNewsWire
4 weeks ago
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27
ARLINGTON, Va., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth quarter and full-year periods ended December 31, 2024 before market open on Thursday, February 27, 2025.
Positive
Zacks Investment Research
1 month ago
DH or PRVA: Which Is the Better Value Stock Right Now?
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two companies is the best option for those looking for undervalued stocks?
Positive
Zacks Investment Research
2 months ago
DH vs. PRVA: Which Stock Is the Better Value Option?
Investors with an interest in Medical Info Systems stocks have likely encountered both Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks presents investors with the better value opportunity right now?
Positive
Zacks Investment Research
2 months ago
DH vs. PRVA: Which Stock Should Value Investors Buy Now?
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now?
Neutral
Zacks Investment Research
3 months ago
DH or PRVA: Which Is the Better Value Stock Right Now?
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now?
Neutral
Seeking Alpha
3 months ago
Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President- Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Andrew Mok - Barclays Richard Close - Canaccord Genuity Jailendra Singh - Truist Securities Jamie Perse - Goldman Sachs Sameer Patel - Evercore ISI Matthew Gillmor - KeyBanc David Larsen - BTIG Jeff Garro - Stephens Ryan Langston - TD Cowen Daniel Grosslight - Citi Olivia Miles - Baird Jack Slevin - Jeffries Jessica Tassan - Piper Sandler Thomas Kelliher - RBC Capital Markets Adam Ron - Bank of America Operator Thank you for standing by.
Neutral
Zacks Investment Research
3 months ago
Compared to Estimates, Privia Health (PRVA) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Negative
Zacks Investment Research
3 months ago
Privia Health (PRVA) Misses Q3 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago.
Neutral
GlobeNewsWire
3 months ago
Privia Health Reports Third Quarter 2024 Financial Results
ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024.
Positive
Zacks Investment Research
3 months ago
Privia Health (PRVA) Earnings Expected to Grow: Should You Buy?
Privia Health (PRVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Charts implemented using Lightweight Charts™